510(k) K834464
K834464 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "TDX PROCAINAMIDE". The FDA issued a decision of Substantially Equivalent on February 3, 1984. The device falls under product code LAR (Enzyme Immunoassay, Procainamide), a Class II device regulated under 21 CFR 862.3320. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 3, 1984
- Date Received
- December 20, 1983
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Procainamide
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type